Clinical trials show progress in migraine frequency, skin cancer prevention

-
2:38
Sunny start to Election Day with rain and snow likely Tuesday...
-
1:34
Milwaukee event to honor César Chávez with virtual youth celebration
-
4:08
UW Health official discusses Damian Lillard’s health and more
-
3:52
Taking a peek ahead at springtime fun in Racine County
-
3:36
Natalie’s Everyday Heroes: Bernie’s Book Bank gives out millions...
-
2:34
’Take your lies and shove them’: Schimel takes final shots...
-
1:41
Crawford makes final pitch to voters during rally in Madison...
-
3:12
While polls show close Supreme Court race, betting markets heavily...
-
1:05
Couple gets engaged at Brewers home opener in front of Bob Uecker...
-
1:52
Brewers fans celebrate Opening Day with parties at Milwaukee...
-
1:44
Last-minute reminders before you vote in Tuesday’s spring election
-
1:47
Fight at Mayfair Mall goes viral after video shows security K-9...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.